Citius Pharmaceuticals
CTXR
CTXR
11 hedge funds and large institutions have $499K invested in Citius Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$120K | |
| 2 | +$81.2K | |
| 3 | +$38K | |
| 4 |
Morgan Stanley
New York
|
+$29K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$10K |
Top Sellers
| 1 | -$768K | |
| 2 | -$29K | |
| 3 | -$6.56K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1K |